Differences in risk factors and drug susceptibility between Mycobacterium avium and Mycobacterium intracellulare lung diseases in China

International Journal of Antimicrobial Agents
Zhijian ZhangChangting Liu

Abstract

The aim of this study was to investigate the differences in risk factors and drug susceptibility between Mycobacterium avium and Mycobacterium intracellulare lung diseases in China. In total, 452 nontuberculous mycobacteria (NTM) strains isolated from patients with NTM lung diseases in four specialised TB hospitals were enrolled in this study. The minimum inhibitory concentration (MIC) was used to evaluate the drug susceptibility of M. avium and M. intracellulare isolates. In addition, demographic and clinical characteristics of patients with NTM lung diseases caused by M. avium and M. intracellulare were analysed. Of 452 NTM isolates, M. intracellulare (188; 41.6%) was the most frequently isolated organism. The percentages of moxifloxacin- and linezolid-resistant strains among the M. intracellulare isolates were significantly lower than those among the M. avium group (P=0.003 and P<0.001, respectively). In contrast, M. avium harboured a lower proportion of rifampicin-resistant strains than M. intracellulare (P=0.005). Among patients with M. intracellulare lung diseases, the percentages of patients aged >64 years and patients with chronic obstructive pulmonary disease (COPD) were significantly higher than among patients with M....Continue Reading

References

Dec 1, 1989·The Journal of Infectious Diseases·L S GuthertzJ M Janda
Sep 28, 1989·The New England Journal of Medicine·D S PrinceJ E Fish
Nov 17, 2004·International Journal of Systematic and Evolutionary Microbiology·Toïdi Adékambi, Michel Drancourt
Feb 6, 2007·American Journal of Respiratory and Critical Care Medicine·David E GriffithUNKNOWN Infectious Disease Society of America
Nov 17, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P Maureen CassidyKevin L Winthrop
May 29, 2010·Emerging Infectious Diseases·Eduardo Hernández-Garduño, R Kevin Elwood
Jun 12, 2010·American Journal of Respiratory and Critical Care Medicine·D Rebecca PrevotsKenneth N Olivier
Jul 6, 2012·Clinical Microbiology Reviews·Barbara A Brown-ElliottRichard J Wallace
Aug 28, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·H-B XuL Li
Jan 15, 2014·Annals of Laboratory Medicine·Hyun Soo KimYoung-Kyu Sun
Jan 28, 2014·Annals of the American Thoracic Society·Giovanni SattaMarc Lipman

❮ Previous
Next ❯

Citations

Mar 1, 2017·Antimicrobial Agents and Chemotherapy·Yu PangYanlin Zhao
Mar 10, 2017·The European Respiratory Journal·Yu PangYanlin Zhao
Dec 4, 2019·Antimicrobial Agents and Chemotherapy·Wenzhu DongJie Lu
Sep 20, 2017·The Journal of Antimicrobial Chemotherapy·Devyani DeshpandeTawanda Gumbo
Aug 29, 2018·Antimicrobial Agents and Chemotherapy·Jin ShiYu Pang
Jan 14, 2017·Frontiers in Microbiology·Yanming LiChen Wang
Nov 2, 2020·Diagnostic Microbiology and Infectious Disease·Yuanyuan TangWanwei Li
Mar 10, 2021·Current Microbiology·Wang ChunfangWang Chunfeng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
X Xia, X Gui
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
Y ObayashiJ Takahara
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
C-T HuangP-C Yang
© 2021 Meta ULC. All rights reserved